Skip to content
Menu

Head-to-head dispatch

Fifty 410 vs Queen RX

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #295
Fifty 410

Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A and 503B.

$99/mo (all doses, compounded) sema · $133/mo (starting dose, compounded) tirz · Verified July 25, 2026

Marked down on: Does not bill insurance directly

FDAWarning letter issued to Aspen Aesthetics dba Fifty 410 in February 2026. See the FDA warning-letter database.

vs
Dispatch #114Desk pick
Queen RX

Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

$100/mo (quarterly plan, compounded) sema · Verified July 20, 2026

Marked down on: No LegitScript or PCAB accreditation

Queen RX takes this head-to-head with the higher Desk Score, 74/100 (C) against 62/100 (C) for Fifty 410. Fifty 410 still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Fifty 410

62/100

C

Overall

Queen RX

74/100

C

Price transparency

84
76

State access

24
78

Molecule range

66
71

Onboarding speed

70
74

Support responsiveness

74
76

Licensing & trust

52
63

The spec sheet

FieldFifty 410Queen RX
Semaglutide$99/mo (all doses, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$133/mo (starting dose, compounded)Not listed on Queen RX's site (checked July 20, 2026)
CoverageNot listed on Fifty 410's site (checked July 25, 2026)45 states
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forBudget-focused buyers wanting transparent no-membership compounded GLP-1 pricing.Budget-conscious patients seeking low-cost compounded GLP-1.
Desk Score62/100C74/100C

The verdict

Desk pick — Queen RX

Queen RX takes this head-to-head with the higher Desk Score, 74/100 (C) against 62/100 (C) for Fifty 410. Fifty 410 still holds its ground where its strengths line up with yours.

Choose Fifty 410 if…

Budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing.

$99/mo (all doses, compounded) sema · $133/mo (starting dose, compounded) tirz

FDAWarning letter issued to Aspen Aesthetics dba Fifty 410 in February 2026. See the FDA warning-letter database.

Choose Queen RX if…

Budget-conscious patients seeking low-cost compounded GLP-1.

$100/mo (quarterly plan, compounded) sema · 45 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Fifty 410 · Queen RX.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.